Hjem › Metastatisk kreft › Rhode Island › Providence
Kliniske studier for Metastatisk kreft i Providence, RI
9 studier for Metastatisk kreft søker deltakere på steder i og rundt Providence (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- Women and Infants Hospital, Providence
- Roger Williams Medical Center, Providence
TLR9 Immunotherapy for Peritoneal Carcinomatosis
RekruttererFase 1
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Rhode Island Hospital, Providence
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Providence
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruttererFase 3
- Women & Infants Hospital, Providence
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Lifespan Cancer Institute, Providence
A Study of PYX-201 in Advanced Solid Tumors
RekruttererFase 1
- Rhode Island Hospital, Providence
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RekruttererFase 1/2
- Brown University Health Cancer Institute, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Providence
Metastatisk kreft-studier i andre byer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Washington, DC43 studier
- Dallas, TX42 studier
Andre studier i Providence
- Eggstokkreft15 studier
- Endometriekreft14 studier
- Fedme14 studier
- Ikke-småcellet lungekreft12 studier
- Kreft (alle typer)12 studier
- Crohns sykdom12 studier
- Brystkreft11 studier
- Ulcerøs kolitt11 studier
- Akut myelogen leukemi10 studier
- Overvekt9 studier
- Alkoholbrukforstyrrelse (AUD)8 studier
- Alzheimers sykdom8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.